ARDS - Aridis Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4434
Avg. Estimate-0.38-0.81-3.26-3.19
Low Estimate-0.88-0.94-3.78-4.05
High Estimate0.75-0.55-2.21-2.65
Year Ago EPS-1.97-0.67-7.45-3.26
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4444
Avg. Estimate4.41M690k6.26M2.25M
Low Estimate400kN/A2MN/A
High Estimate15M1.5M16.02M3M
Year Ago Sales1.02M1.39M2.76M6.26M
Sales Growth (year/est)331.50%-50.40%127.10%-64.10%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-1.05-1.55-0.87-0.84
EPS Actual-1.97-0.67-0.99-1.03
Difference-0.920.88-0.12-0.19
Surprise %-87.60%56.80%-13.80%-22.60%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.38-0.81-3.26-3.19
7 Days Ago-0.38-0.81-3.26-3.19
30 Days Ago-0.38-0.81-3.26-3.19
60 Days Ago-0.31-0.67-2.78-3.02
90 Days Ago-0.66-0.57-3.06-2.8
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesARDSIndustrySectorS&P 500
Current Qtr.80.70%N/AN/A-0.02
Next Qtr.-20.90%N/AN/A0.07
Current Year56.20%N/AN/A-0.02
Next Year2.10%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A